GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
D

Doseology Sciences MOOD.CN · CAD

N/A · Canadian Securities Exchange · 🇨🇦 Canada

Compare

0.10

0.00%

Close of 9 Nov 2026, in CAD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About Doseology Sciences

Its shares trade on Canadian Securities Exchange under the ticker MOOD.CN. It has been listed since 15 November 2021. In the fiscal year to 30 June 2025, it reported revenue of C$42,556 and a net loss of C$447,788. At that date it held total assets of C$1.5m and shareholders' equity of C$1.4m.

Doseology Sciences, Inc. engages in the management and operation of functional mushroom products, cannabis nursery, clinical operations, as well as research and development activities. The company is headquartered in Vernon, British Columbia. The company went IPO on 2021-11-15. The firm is engaged in researching, developing, and manufacturing psychotropic drugs. The company is involved in the manufacturing of controlled compounds and facilitates the development of psychotropic and psychedelic treatment therapies. The firm produces a variety of natural, synthetic, and biosynthetic products. The company offers white and private label products.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
N/A
Industry
N/A
Listed since
15 Nov 2021

Leadership

Pay as last reported

  • Mr. Timothy CorkumPresident, Chief Operating Officer
  • Mr. Chris JacksonChief Executive Officer, Director, since 2025
  • Mr. Christopher CherryChief Financial Officer$2,000
  • Pol. Capt. Zara KanjiIndependent Director
  • Mr. Scott ReevesIndependent Director, since 2019
  • Mr. Daniel ViceIndependent Director

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • Doseology Sciences Inc. manages functional mushroom products in Vernon, CA.
  • The company produces white and private label products for diverse markets.
  • Doseology Sciences Inc. focuses on research and development of psychotropic drugs.

Weaknesses

  • Doseology Sciences Inc. operates in the cannabis nursery sector in Vernon, CA.
  • The company's manufacturing of controlled compounds may face regulatory challenges.
  • Doseology Sciences Inc. is engaged in clinical operations with limited market presence.

Opportunities

  • Doseology Sciences Inc. can expand its psychotropic treatment therapies in the Health Care sector.
  • The company's biosynthetic products offer growth potential in Information Technology.
  • Doseology Sciences Inc. can leverage its natural products for Consumer Discretionary segments.

Threats

  • Doseology Sciences Inc. faces competition in the cannabis nursery market in Vernon, CA.
  • Regulatory scrutiny on controlled compounds may impact manufacturing operations.
  • The company's reliance on clinical operations could be affected by market volatility.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.